EYE AS A PREDICTOR OF CARDIOVASCULAR PATHOLOGY IN PATIENTS WITH DIABETES MELLITUS

Authors

  • Poltorak V. V. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Kravchun N. A. SI «V. Danilevsky Institute of Endocrine Pathology Problems of AMS of Ukraine», Kharkiv, Ukraine
  • Gorshunska M. Yu. Kharkiv Medical Academy of Postgraduate Education https://orcid.org/0000-0002-4402-9441

DOI:

https://doi.org/10.21856/j-PEP.2011.2.12

Keywords:

diabetes mellitus

Abstract

The global prevalence of diabetes mellitus (diabetes) reached 6.6% (285 million patients) in 2010 and is expected to be 7.8% (438 million patients) in 2030. Among patients with coronary heart disease, the incidence of diabetes is higher, than in the population, and the incidence of cardiovascular disease is higher in patients with diabetes. The Cardiovascular Health Study, which included individuals 65 years of age and older, found that the incidence of clinical or subclinical cardiovascular disease was 70% in individuals with normal glucose levels, 77% in people with advanced glucose, and 86% - for people with first-time diagnosed or verified diabetes mellitus

References

IDF Diabetes Atlas, Fourth Edition, 2009.

Pyorala K. Diabetes and atherosclerosis: an epidemiologic view [Text] / K. Pyorala, M. Laakso, M. Uusitupa // Diabetes. Metab. Rev. — 1987. — Vol. 3 (2). — P. 463–524.

Libby P. Inflammation and atherosclerosis [Text] / P. Libby, P. M. Ridker, A. Maseri // Circulation. — 2002. — Vol. 105 (9). — P. 1135–1143.

Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorder [Text] / J. I. Barziay, C. F. Spiekerman, L. H. Kuller [et al.] // Diabetes Care. — 2001. — Vol. 24. — P. 1233–1239.

Moncada S. Nitric oxide: physiology, pathophysiology, and pharmacology [Text] / S. Moncada, R. M. Palmer, E. A. Higgs // Pharmacol. Rev. — 1991. — Vol. 43. — P. 109–142.

Shore A. Vascular biology and physiology. In a textbook of vascular medicine [Text] / A. Shore, J. Tooke, D. Lowe // Arnold. Bath. — 1996. — P. 7–42.

Vita J. A. Endothelial function: a barometer for cardiovascular risk? [Text] / J. A. Vita, J. F. Keaney // Circulation. — 2002. — Vol. 106. — P. 640–642.

Davignon J. Role of endothelial dysfunction in atherosclerosis [Text] / J. Davignon, P. Ganz // Circulation. — 2004. — Vol. 109. — Suppl. 1. — P. 27–32.

Deanfield J. E. Endothelial function and dysfunction: testing and clinical relevance [Text] / J. E. Deanfield, J. P. Halcox, T. J. Rabelink // Circulation. — 2007. — Vol. 115. — P. 1285–1295.

Sch¨achinger V. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease [Text] / V. Sch¨achinger, M. B. Britten, A. M. Zeiher // Circulation. — 2000. — Vol. 101. — P. 1899–1906.

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction [Text] / J. A. Suwaidi, S. Hamasaki, S. T. Higano [et al.] // Circulation. — 2000. — Vol. 101. — P. 948–954.

Prognostic value of coronary vascular endothelial dysfunction [Text] / J. P. Halcox, W. H. Schenke, G. Zalos [et al.] // Circulation. — 2002. — Vol. 106. — P. 653–658.

Kannel W. B. Diabetes and cardiovascular disease: the Framingham Study [Text] / W. B. Kannel, D. L. McGee // JAMA. — 1979. — Vol. 241. — P. 2035–2038.

Hayden M. R. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy [Text] / M. R. Hayden, S. C. Tyagi // Cardiovasc. Diabetol. — 2002. — P. 1–3.

Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women [Text] / D. S. Celermajer, K. E. Sorensen, D. J. Spiegelhater [et al.] // J. Am. Coll. Cardiol. — 1994. — Vol. 24. — P. 471–476.

Age-related reduction of NO availability and oxidative stress in humans [Text] / S. Taddei, A. Virdis, L. Ghiadoni [et al.] // Hypertension. — 2001. — Vol. 38. — P. 274–279.

Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent

dilation and upregulation of nuclear factor-kB [Text] / A. J. Donato, I. Eskurza, A. E. Silver [et al.] // Circ. Res. — 2007. — Vol. 100. — P. 1659–1666.

Tooke J. E. Microvascular functional abnormalities in diabetes: the role of the endothelium [Text] / J. E. Tooke, S. J. Morris, A. C. Shore // Diabetes. Res. Clin. Pract. — 1996. — Vol. 31. — P. S127 —S132.

Microcirculation in hypertension: a new target for treatment? [Text] / B. I. Levy, G. Ambrosio, A. R. Pries [et al.] // Circulation. — 2001. — Vol. 104. — P. 735–740.

Capillary recruitment is impaired in essential hypertension and relates to insulin’s metabolic and vascular actions [Text] / E. H. Serne, R. O. B. Gans, J. C. Maaten [et al.] // Cardiovasc. Res. — 2001. — Vol. 49. — P. 161–168.

Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome [Text] / E. H. Serne, R. T. de Jongh, E. C. Eringa [et al.] // Hypertension. — 2007. — Vol. 50. — P. 204–211.

Seals D. R. Stiffening our resolve against adult weight gain [Text] / D. R. Seals, P. E. Gates // Hypertension. — 2005. — Vol. 45. — P. 175–177.

Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance [Text] / R. T. de Jongh, E. H. Serne, R. G. IJzerman [et al.] // Circulation. — 2004b. — Vol. 109. — P. 2529–2535.

Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy [Text] / R. T. de Jongh, E. H. Serne, R. G. IJzerman [et al.] // Diabetes. — 2004a. — Vol. 53. — P. 2873–2882.

Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals [Text] / R. T. de Jongh E. H. Serne, R. G. Ijzerman [et al.] // J. Clin. Endocrinol. Metab. — 2006. — Vol. 91. — P. 5100–5106.

Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and noninsulin-dependent

diabetic subjects [Text] / H. Miettinen, S. M. Haffner, S. Lehto [et al.] // Stroke. — 1996. — Vol. 27. — P. 2033–2039.

Retinopathy and risk of congestive heart failure [Text] / T. Y. Wong, W. Rosamond, P. P. Chang [et al.] // JAMA. — 2005. — Vol. 293. —P. 63–69.

The Framingham Heart Study and the Framingham Eye Study. Diabetic retinopathy and cardiovascular disease in type II diabetics [Text] / R. Hiller, R. D. Sperduto, M. J. Podgor [et al.] // Am. J. Epidemiol. — 1988. — Vol. 128. — P. 402–409.

Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes [Text] / E. Faglia, F. Favales, P. Calia [et al.] // Diabetes Care. — 2002. — Vol. 25. — P. 2032–2036.

Association of ocular disease and mortality in a diabetic population [Text] / R. Klein, B. E. Klein, S. E. Moss [et al.] // Arch Ophtalmol. — 1999. — Vol. 117. — P. 1487–1495.

Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study [Text] / N. Cheung, J. J. Wang, R. Klein [et al.] // Diabetes Care. — 2007. — Vol. 30. — P. 1742–1746.

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors [Text] / G. A. Nichols, T. A. Hillier, J. R. Erbey [et al.] // Diabetes Care. — 2001. — Vol. 24. — P. 1614–1619.

Bell D. S. Heart failure: the frequent, forgotten, and often fatal complication of diabetes [Text] / D. S. Bell // Diabetes Care. — 2003. — Vol. 26. — P. 2433–2441.

Heart failure prevalence, incidence, and mortality in the elderly with diabetes [Text] / A. G. Bertoni, W. G. Hundley, M.W. Massing [et al.] // Diabetes Care. — 2004. — Vol. 27. — P. 699–703.

Galderisi M. Diastolic dysfunction and diabetic cardiomiopathy: evaluation by Doppler echocardiography [Text] / M. Galderisi // J. Am. Coll. Cardiol. — 2006. — Vol. 48. — P. 1548–1551.

Boundina S. Diabetic cardiomyopathy revisited [Text] / S. Boundina, E. D. Abel // Circulation. — 2007. — Vol. 115. — P. 3213–3223.

Factor S. M. Capillary microaneurysms in the human diabetic heart [Text] / S. M. Factor, E. M. Okun, T. Minase // N. Engl. J. Med. — 1980. — Vol. 302. — P. 384–388.

Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus [Text] / T. Akasaka, K. Yoshida, T. Hozumi [et al.] // J. Am. Coll. Cardiol. — 1997. — Vol. 30. — P. 935–941.

Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes [Text] / M. F. Di Carli, J. Janisse, G. Grunberger [et al.] // J. Am. Coll. Cardiol. — 2003. — Vol. 41. — P. 1387–1393.

Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels [Text] / H. Miura, R. E. Wachtel, F. R. Loberiza [et al.] // Circ. Res. — 2003. — Vol. 92. — P. 151–158.

Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy

after replenishment of local vascular endothelial growth factor [Text] / Y. S. Yoon, S. Uchida, O. Masuo [et al.] // Circulation. — 2005. — Vol. 111. — P. 2073–2085.

Kannel W. B. Role of diabetes in congestive heart failure: the Framingham study [Text] / W. B. Kannel, M. Hjortland, W. P. Castelli // Am. J. Cardiol. — 1974. — Vol. 34. — P. 29–34.

Schaffer W. B. Development of a cardiomyopathy in a middle of noninsulin-dependent diabetes [Text] / S.W. Schaffer, B. H. Tan, G. L. Wilson // Am. J. Physiol. — 1985. — Vol. 248. — P. 179–185.

Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women [Text] / A. Juutilainen, S. Lehto, T. Ronnemaa [et al.] // Diabetes Care. — 2007. — Vol. 30. — P. 292–299.

Diabetic retinopathy and risk of heart failure [Text] / N. Cheung, J. J. Wang, S. L. Rogers [et al.] // J Am Coll Cardiol. — 2008. — Vol. 51. — P. 1573–1578.

Moreno P. R. New aspects in the pathogenesis of diabetic atherothrombosis [Text] / P. R. Moreno, V. Fuster // J. Am. Coll. Cardiol. — 2004. — Vol. 44. — P. 2293–2300.

The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [Text] // N. Engl. J. Med. — 1993. — Vol. 329. — P. 977–986.

The Diabetes Control and Complications Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial [Text] // Kidney Int. — 1995. — Vol. 47. — P. 1703–1720.

UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [Text] // Lancet. — 1998. —

Vol. 352. — P. 837–853.

UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis [Text] / I. M. Stratton, E. M. Kohner, S. J. Aldington [et al.] // Diabetologia. — 2001. — Vol. 44. — P. 156 –163.

10-Year follow-up of intensive glucose control in type 2 diabetes [Text] / R. R. Holman, S. K. Paul, M. A. Bethel [et al.] // N. Engl. J. Med. — 2008. — Vol. 359. — P. 1577–1589.

Diabetes Control and Complications Trial (DCCT) / Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Beneficial effects of intensive therapy of diabetes among adolescents: outcomes after the conclusion of

the Diabetes Control and Complications Trial (DCCT) [Text] / N. H. White, P. A. Cleary, W. Dahms [et al.] // J. Pediatr. — 2001. —

Vol. 139. — P. 804–812.

Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents [Text] / N. H. White, W. Sun, P. A. Cleary [et al.] // Diabetes.– 2010. — Vol. 59. — P. 1244–1253.

Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial [Text] // J. Pediatr. — 1994. — Vol. 125. — P. 177–188

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy: The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group [Text] // N. Engl.

J. Med. — 2000. — Vol. 342. — P. 381–389.

Mattila T. K. Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus [Text] / T. K. Mattila, A. de Boer // Drugs. — 2010. — Vol. 70 (17). — P. 2229–2245.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [Text] / F. Ismail-Beigi, T. Craven, M. A. Banerji [et al.] // Lancet. — 2010. — Vol. 376. — P. 419–430.

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes [Text] / D. M. Nathan, P. A. Cleary, J. Y. Backlund [et al.] // N. Engl. J. Med. — 2005. — Vol. 353. — P. 2643–2653.

Leahy J. L. Does early use of insulin reduce complications of diabetes? [Text] / J. L. Leahy // International Forum for the Advancement of Diabetes Research and Care: Abstract book. — 29–30 April (Greece). — 2011. — P. 16–17.

Intensive glucose control and macrovascular outcomes in type 2 diabetes [Text] / F. M. Turnbull, C. Abraira, R. J. Andersen [et al.] // Diabetologia. — 2009. — Vol. 52, № 11. — P. 2288–2298.

Biomedical risk factors for decreased cognitive unctioning in type 1 diabetes: an 18 year followup of the Diabetes Control and Complications Trial (DCCT) cohort [Text] / A. M. Jacobson, C. M. Ryan, P. A. Cleary [et al.] // Diabetologia. — 2011. —

Vol. 54. — P. 245–255.

Banerji M. A. Efficacy and goal attainment with insulin glargine vs comparators [Text] / M. A. Banerji, M. Baron, L. Blonde // Diabetologia. — 2010. — Vol. 53. — P. S389.

A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-na¨ıve people with type 2 diabetes [Text] / J. Rosenstock, M. Davies, P. D. Home [et al.] // Diabetologia. — 2008. — Vol. 51. — P. 408–416.

Statement by an American Association of Clinical Endocrinologists / American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control [Text] / H.W. Rodbard, P. S. Jellinger, J. A. Davidson [et al.] // Endocr. Pract. — 2009. — Vol. 15, № 6. – P. 540–559.

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long term, randomised, open-label study [Text] / J. Rosenstock, V. Fonseca, J. B. McGill [et al.]

// Diabetologia. — 2009. — Vol. 52. — P. 1778–1788.

Древаль А. В. Лечение сахарного диабета и сопутствующих заболеваний [Текст] / А. В. Древаль // М.: Эксмо — 2010. — 352 с.

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus [Text] / R. A. Whitmer, A. J. Karter, K. Yaffe [et al.] // JAMA. — 2009. — Vol. 301, № 15. — P. 1565–1572.

Insulin as an antiinflammatory and antiatherogenic modulator [Text] / P. Dandona, A. Chaudruhi, H. Ghanim, P. Mohanty // J. Am. Coll. Cardiol. — 2009. — Vol. 53 (Suppl. 5). — P. S14–20.

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy [Text] / L. Monnier, C. Colette, E. Mas [et al.] // Diabetologia. — 2010. — Vol. 53, № 3. — P. 562–571.

Garg S. K. New insights into fasting blood glucose and glycemic variability [Text] / S. K. Garg // International Forum for the Advancement of Diabetes Research and Care: Abstract book. — 29–30 April (Greece). — 2011. — P. 10–11.

The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up [Text] / T. Takao, T. Ide, H. Yanagisava [et al.] // Diabetes Res. Clin. Pract. — 2010. — Vol. 89 (3). — P. 296–302.

IDF Diabetes Atlas, Second Edition, 2003.

Downloads

Published

2011-06-02

How to Cite

Poltorak, V. V., Kravchun, N. A., & Gorshunska, M. (2011). EYE AS A PREDICTOR OF CARDIOVASCULAR PATHOLOGY IN PATIENTS WITH DIABETES MELLITUS. Problems of Endocrine Pathology, 36(2), 79-87. https://doi.org/10.21856/j-PEP.2011.2.12

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >> 

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.